Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

LINDEVANG DYREKLINIK ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   6.5% 3.8% 2.9% 7.8% 3.3% 2.4% 14.6% 14.6%   Credit score (0-100)   38 52 58 30 55 62 15 15   Credit rating   BBB BBB BBB BB BBB BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   1,734 1,767 1,308 1,447 1,546 1,776 0.0 0.0   EBITDA   67.0 233 328 -117 125 410 0.0 0.0   EBIT   67.0 233 328 -122 113 372 0.0 0.0   Pre-tax profit (PTP)   66.9 231.5 327.4 -127.4 104.3 333.9 0.0 0.0   Net earnings   52.2 180.5 255.4 -123.9 104.4 265.8 0.0 0.0   Pre-tax profit without non-rec. items   66.9 231 327 -127 104 334 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   0.0 19.5 14.6 9.8 187 589 0.0 0.0   Shareholders equity total   144 324 580 456 560 726 546 546   Interest-bearing liabilities   0.0 0.0 0.0 0.0 0.0 380 0.0 0.0   Balance sheet total (assets)   340 612 1,046 842 966 1,609 546 546   Net Debt   -134 -368 -818 -666 -435 -347 -546 -546     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,734 1,767 1,308 1,447 1,546 1,776 0.0 0.0   Gross profit growth   105.1% 1.9% -26.0% 10.6% 6.9% 14.9% -100.0% 0.0%   Employees   0 0 2 3 3 4 0 0   Employee growth %   0.0% 0.0% 0.0% 50.0% 0.0% 33.3% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   340 612 1,046 842 966 1,609 546 546   Balance sheet change%   19.4% 80.0% 71.0% -19.5% 14.8% 66.5% -66.1% 0.0%   Added value   67.0 232.8 328.3 -117.0 118.0 409.8 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 20 -5 -10 166 365 -589 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 -1.0 1.0 2.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   3.9% 13.2% 25.1% -8.4% 7.3% 21.0% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   21.5% 48.9% 39.6% -12.9% 12.5% 28.9% 0.0% 0.0%   ROI %   56.9% 99.5% 72.6% -23.5% 22.3% 43.8% 0.0% 0.0%   ROE %   44.3% 77.1% 56.5% -23.9% 20.5% 41.3% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   42.3% 53.0% 55.4% 54.2% 58.0% 45.1% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -199.8% -158.0% -249.1% 569.1% -348.7% -84.6% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.0% 0.0% 52.4% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 0.0% 0.0% 20.2% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   1.1 2.0 1.9 1.8 1.4 1.5 0.0 0.0   Current Ratio   1.8 2.5 2.2 2.2 1.8 1.8 0.0 0.0   Cash and cash equivalent   133.8 367.9 817.7 665.7 435.1 727.0 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   139.3 344.4 544.7 444.9 307.2 413.9 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 164 -39 39 102 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 164 -39 42 102 0 0   EBIT / employee   0 0 164 -41 38 93 0 0   Net earnings / employee   0 0 128 -41 35 66 0 0